Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    24131140 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Drug: Nab-Paclitaxel and Gemcitabine
2 Completed
Has Results
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
Condition: Metastatic Pancreatic Cancer
Interventions: Drug: Albumin-bound paclitaxel;   Drug: Gemcitabine

Indicates status has not been verified in more than two years